US Patent 8124773 1,8-naphthyridine compounds for the treatment of cancer
Patent 8124773 was granted and assigned to Sunesis Pharmaceuticals Inc on February, 2012 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 12, 2007
0
Date of Patent
February 28, 2012
0
Patent Application Number
12304750
0
Patent Inventor Names
Marc J. Evanchik
0
Daniel C. Adelman
0
Jeffrey A. Silverman
0
Jeffrey William Jacobs
0
Anantha Sudhakar
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8124773 1,8-naphthyridine compounds for the treatment of cancer
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.